ETFs with BIIB as a Top 10 Holding*Sponsored by:
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|8.86%||iShares NASDAQ Biotechnology Index Fund (IBB)||+24.64 (12.64%)|
|5.54%||PowerShares Dynamic Biotech &Genome (PBE)||+3.66 (11.17%)|
|4.98%||First Trust Amex Biotechnology Index Fund (FBT)||+2.86 (4.45%)|
|3.19%||PowerShares Dynamic Pharmaceuticals (PJP)||+6.98 (15.41%)|
|2.9%||Select Sector SPDR Fund - Health Care (XLV)||+4.54 (8.98%)|
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Biogen Idec is a global biotechnology company focused on discovering, developing, manufacturing and marketing products for the treatment of neurological disorders and other serious diseases. Patients worldwide benefit from our significant products used for the treatment of multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, Crohn’s disease, chronic lymphocytic leukemia and psoriasis. Marketed Products We have four therapeutic products on the market, which are summarized in the tables below. ... More ...